Concepedia

Expression of Bcl-2, p53, and MDM2 in Localized Prostate Cancer With Respect to the Outcome of Radical Radiotherapy Dose Escalation

Roy Vergis, Catherine M. Corbishley, Karen Thomas, Alan Horwich, Robert Huddart, Vincent Khoo, Rosalind A. Eeles, Matthew R. Sydes, Colin S. Cooper, David P. Dearnaley,

International Journal of Radiation Oncology*Biology*Physics · 2010 · 32 citations · 37 references

DOI

Concepts

References

37

Cancer Statistics, 2006

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth M. Ward et al. · CA A Cancer Journal for Clinicians · 2006 · 5.3K citations · Full text

, , +16

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Jamil Momand, Gerard P. Zambetti, David C. Olson et al. · Cell · 1992 · 3.1K citations

, , +10

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

Deborah A. Kuban, Susan L. Tucker, Lei Dong et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 1.2K citations

, , +11

20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer

Peter C. Albertsen · JAMA · 2005 · 1.2K citations

, , +8

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

Timothy J. McDonnell, Patricia Troncoso, Shawn Brisbay et al. · PubMed · 1992 · 1.1K citations

, , +17